SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2419The latest study of Velade ,that shows an about 20-25% better effect than the coManfred Sondermann-6/22/2005
2418from wsj 6/19 "...Millennium Pharmaceuticals added $1.14, or 14%, to $9.41 bob zagorin-6/20/2005
2417Millennium jumps after TV plug, drug news By Val Brickates Kennedy, MarketWatch bob zagorin-6/17/2005
2416cramer was raving about mlnm today after hours and saying buy, buy, buy. probablbob zagorin-6/16/2005
2415Biotech Drug Shows Promise Against Ulcerative Colitis Researchers also hope for bob zagorin-6/16/2005
2414Angela Dispenzieri at the Mayo clinics wrote an accompanying editorial in the saboronate-6/16/2005
2413New England Journal of Medicine Publishes Studies of VELCADE(R) (bortezomib) forbob zagorin-6/16/2005
2412VELCADE(R) (bortezomib) for Injection Showed Positive Activity Across a Variety mopgcw-6/14/2005
2411Thanks for digging up the abstract. Velcade seems to have much untapped potentiIan@SI-6/10/2005
2410At first I didn't think so, but you might be right: >>J Neurosci. 200tuck-6/10/2005
2409Might there also be an indication of activity in Alzheimer's??? IanIan@SI-6/10/2005
2408[Serum amyloid A in pathogenesis of acute inflammation; regulation by proteasometuck-6/10/2005
2407Looks like this was worth all of 4 cents on the stock price... ++++++++++++++++Ian@SI-6/8/2005
2406I hadn't followed MLNM closely enough to realize how weak it has been. If ontom pope-6/6/2005
24058K filed: tem 7.01 Regulation FD Diformer_pgs-6/6/2005
2404[Inhibition of proteasome and aggresome function is synergistic against MM] >tuck-6/4/2005
2403[More on TRAIL and Velcade: bladder and prostate cancer] >>Cancer Res. 20tuck-6/3/2005
2402Proteasome inhibition as therapy Abstract No: 3122 Author(s): D. Chauhan, L. Catmicrocapfun-6/2/2005
2401More from Ken Anderson on Velcade... Public release date: 2-Jun-2005 Contact: Ian@SI-6/2/2005
2400synergy, synergy...... slowly but surely, we're turning the corner againstscaram(o)uche-6/1/2005
2399 >>Clinical Cancer Research Vol. 11, 4259-4265, June 1, 2005 Cooperativetuck-6/1/2005
2398OVERVIEW OF NEW THERAPIES AND FUTURE DIRECTIONS K Anderson. Dana-Farber Cancer IIcebrg-5/31/2005
2397[>>Br J Haematol. 2005 Jun;129(5):607-14. Long-term outcomes of previoustuck-5/28/2005
2396>>ORLANDO, Fla., May 14 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticatuck-5/14/2005
2395bortezomib & radiation in head/neck Abstract No: 5592 Author(s): B. A. ConlIan@SI-5/13/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News